<DOC>
	<DOCNO>NCT02856516</DOCNO>
	<brief_summary>This randomize , cross-over design . Subjects randomized one three intervention three separate study day , 1 week apart .</brief_summary>
	<brief_title>Glycemic Response Three Oral Nutrition Supplements Persons With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description>Following consent , subject randomize one three arm . After overnight fast intravenous line place blood withdrawal . The subject consume randomly assign intervention . Blood sample glucose insulin level draw specify interval product consume .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Age 2075 yr Type 2 diabetes control diet diet oral agent , exception sulfonylurea glimepiride ( Amaryl ) , glipizide ( Glucotrol/Glucotrol XL ) glyburide ( DiaBeta , Micronase , ( Glynase Prestabs ) ; meglitinides reaglinide ( Prandin ) nateglinide ( Starlix ) ; alphaglucosidase inhibitor acarbose ( Precose ) miglitol ( Glyset ) Hemoglobin A1C le 9.0 % Fasting blood glucose le 180 mg Abnormal thyroid function Creatinine &gt; 2.0 mg/dL Potassium &lt; 3.5 mEq/L Gastrointestinal disease : ulcer , gastritis , diarrhea , gastroparesis , vomit Currently unstable diabetes treatment cancer , heart disease , renal disease Unable give inform consent follow instruction Current insulin therapy insulin therapy within past month Patients pregnant Allergies milk , soy component test product Patient Investigators assessment expect comply treatment Currently participate participate another clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>